Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
56,900
-4,400 (-7.18%)
At close: Dec 5, 2025
144.73%
Market Cap 2.18T
Revenue (ttm) 23.23B
Net Income (ttm) -13.14B
Shares Out 38.26M
EPS (ttm) -343.12
PE Ratio n/a
Forward PE 255.16
Dividend n/a
Ex-Dividend Date n/a
Volume 836,958
Average Volume 596,466
Open 60,500
Previous Close 61,300
Day's Range 55,100 - 60,700
52-Week Range 21,600 - 65,000
Beta 1.35
RSI 57.37
Earnings Date Nov 14, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.